Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 61 entries
View as:

A Novel Nomogram to Predict Severity of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04366024 Org: User:
Start: 01/17/20 End: 12/31/21 Due: 12/31/22

Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02721407 Org: User:
Start: 03/31/16 End: 12/31/19 Due: 12/31/20

A Randomized Trial Of Endovascular Treatment For Acute Posterior Large Vessel Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT04743076 Org: User:
Start: 03/16/21 End: 05/16/24 Due: 05/16/25

A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)

Phase: N/A Priority: Normal
NCT ID: NCT05230914 Org: User:
Start: 01/01/25 End: 06/01/27 Due: 06/01/28

Role of Hypothermia in Endovascular Stroke Thrombectomy

Phase: N/A Priority: Normal
NCT ID: NCT06109376 Org: User:
Start: 12/01/23 End: 03/31/27 Due: 03/31/28

Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

Phase: N/A Priority: Normal
NCT ID: NCT05455034 Org: User:
Start: 08/01/23 End: 06/30/25 Due: 06/30/26

Plasma miRNAs Predict Radiosensitivity of Different Fractionation Regimes in Palliative Radiotherapy for Advanced Non-small Cell Lung Cancer：Multicenter Controlled Study.(RadmiR-01)

Phase: N/A Priority: Normal
NCT ID: NCT03074175 Org: User:
Start: 07/01/17 End: 12/31/19 Due: 12/31/20

A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease

Phase: N/A Priority: Normal
NCT ID: NCT04347369 Org: User:
Start: 01/17/20 End: 12/31/20 Due: 12/31/21

Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

Phase: N/A Priority: Normal
NCT ID: NCT04733742 Org: User:
Start: 05/09/22 End: 02/07/25 Due: 02/07/26

Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Phase: N/A Priority: Normal
NCT ID: NCT02934906 Org: User:
Start: 01/31/17 End: - Due: -

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

Phase: N/A Priority: Normal
NCT ID: NCT04516551 Org: User:
Start: 11/20/20 End: 12/01/22 Due: 12/01/23

Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04160559 Org: User:
Start: 01/11/20 End: 10/30/20 Due: 10/30/21

Efficacy and Safety of Young Health Plasma on Acute Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02913183 Org: User:
Start: 10/31/16 End: 10/31/17 Due: 10/31/18

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05862259 Org: User:
Start: 08/10/23 End: 12/31/25 Due: 12/31/26

Short-term Prednisone to Treat STA Study(SPTSS)

Phase: N/A Priority: Normal
NCT ID: NCT01837433 Org: User:
Start: 03/31/13 End: 12/31/14 Due: 12/31/15

3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03810274 Org: User:
Start: 02/01/12 End: 01/15/19 Due: 01/15/20

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Phase: N/A Priority: Normal
NCT ID: NCT03151005 Org: User:
Start: 07/01/17 End: 04/23/21 Due: 04/23/22

Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04238169 Org: User:
Start: 09/01/20 End: 12/31/23 Due: 12/31/24

A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06947694 Org: User:
Start: 05/20/25 End: 12/31/27 Due: 12/31/28

Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03796364 Org: User:
Start: 09/01/18 End: 07/31/20 Due: 07/31/21

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Phase: N/A Priority: Normal
NCT ID: NCT03073902 Org: User:
Start: 03/25/17 End: 12/10/18 Due: 12/10/19

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05909137 Org: User:
Start: 09/30/24 End: 12/31/26 Due: 12/31/27

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04264039 Org: User:
Start: 04/01/20 End: 04/01/22 Due: 04/01/23

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03461185 Org: User:
Start: 05/01/18 End: 02/20/20 Due: 02/20/21

Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT03788499 Org: User:
Start: 01/11/19 End: 07/30/20 Due: 07/30/21